Michelle Rae Rendon is a Philadelphia, Pennsylvania based nurse practitioner who is specialized as Neonatal nurse. Her current practice location is 800 Spruce St, 2 Cathcart, Philadelphia. Patients can reach her at 215-829-3301. Michelle Rae Rendon is CRNP with specialization in Neonatal and her NPI number (Unique professional ID assigned by NPPES) is 1013171024. Michelle Rae Rendon serve as primary caregivers to newborns. Her duties include performing essential diagnostic tests, monitoring specialized neonatal equipment, dispensing medications, ensuring proper feeding and basic care. Neonatal Nurse Practitioner (NNPs) work under the direction of a neonatal fellow or neonatologist. They care for premature and sick newborns in neonatal intensive care units (NICU), delivery rooms, and emergency rooms. They are the link between the doctors and families of the newborns in times of extreme stress. They also provide education and support to patients’ families.
Complete Profile:
Michelle Rae Rendon speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1013171024
NPI Enumeration Date:
18 Jul, 2008
NPI Last Update On:
18 Jul, 2008
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Michelle Rae Rendon 800 Spruce St, 2 Cathcart Philadelphia, Pennsylvania
Zip:
19107-6130
Phone Number:
215-829-3301
Patients can reach Michelle Rae Rendon at 800 Spruce St, 2 Cathcart, Philadelphia, Pennsylvania or can call to book an appointment on 215-829-3301.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.